Gut Microbiota Interventions: Novel Approaches to Type 2 Diabetes Treatment

In recent years, the gut microbiota has gained attention for its role in the pathogenesis and progression of type 2 diabetes mellitus (T2DM). Studies indicate that gut microbes and their metabolite products (such as Short-chain fatty acid, Trimethylamine/trimethylamine oxide, tryptophan metabolites, etc) can influence T2DM through various mechanisms, including altered gut permeability, endotoxemia, and interactions with bile acids, which in turn affect chronic inflammation and insulin resistance. Despite advancements, the complex network of microbial interactions and the precise mechanisms by which these influence diabetes remain inadequately understood.

This Research Topic aims to delve into the intricate relationship between gut microbiota and T2DM. We seek to unwrap the multifaceted roles of gut microbiota in the disease's onset, progression, and treatment. More specifically, the objective is to explore how microbial composition and metabolites can be manipulated to prevent or ameliorate T2DM, utilizing emerging technologies such as probiotics, prebiotics, gut microbiota transplantation, and antibiotic interventions.

To gather further insights, our research coverage is conceptualized to include:

• Elaborate on the correlations and mechanisms: Examining how changes in gut microbiota and metabolomics correlate with T2DM and its complications.

• Technological innovations in treatment: Research on effective microbial or metabolic product treatments, including the use of probiotics, prebiotics, and gut microbiota transplantation.

We welcome studies not only outlining the range of microbial interactions but also providing actionable solutions for diabetes management through gut microbiota modifications.